Long-term safety of once-daily indacaterol acetate/glycopyrronium bromide/mometasone furoate high-dose, and indacaterol acetate/mometasone furoate high-dose, in Japanese patients with inadequately controlled asthma: Results from two open-label, 52-week studies.
The Journal of asthma : official journal of the Association for the Care of Asthma（2023）
摘要
Supplemental data for this article is available online at.
更多查看译文
关键词
Asthma control,Japan,long-acting β2-adrenergic agonist/inhaled corticosteroid (LABA/ICS),long-acting β2-adrenergic agonist/long-acting muscarinic antagonist/inhaled corticosteroid (LABA/LAMA/ICS),lung function,safety
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要